Who owns SONNET BIOTHERAPEUTC HLDNG I?
- Ticker: SONN
- CUSIP Number: 83548r303
Tip: Access positions for across all investors
Analyze quarterly positions in Sonnet Biotherapeutc Hldng I with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Sonnet Biotherapeutc Hldng I stock
Who bought or sold SONNET BIOTHERAPEUTC HLDNG I this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Citadel Advisors | 29k | $51k | 100% | Dec 2023 |
|
| Vanguard Group | 15k | $26k | 1% | Dec 2023 |
|
| Advisor Group Holdings | 45.00 | $77.998500 | 0% | Dec 2023 |
|
| Wells Fargo & Company | 21.00 | $36.999900 | 91% | Dec 2023 |
|
| Jpmorgan Chase & Co | 19.00 | $32.999200 | 100% | Dec 2023 |
|
| Private Wealth Management Group | 3.00 | $6.000000 | 100% | Dec 2023 |
|
Who sold out of Sonnet Biotherapeutc Hldng I?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| UBS Group | Sep 2023 | 3.7k | $11k |
| Bank of America Corporation | Sep 2023 | 94.00 | $269.817600 |
| IFP Advisors | Sep 2023 | 6.00 | $16.999800 |
| Citigroup | Sep 2023 | 3.00 | $9.000000 |